<html xml:lang="en-us" lang="en-us" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops"><head>
    <link rel="stylesheet" type="text/css" href="../../../../css/base.css" />
<link rel="stylesheet" type="text/css" href="../../../../css/kotobeeInteractive.css" />
<link rel="stylesheet" type="text/css" href="../../../../css/global.css" />
<link rel="stylesheet" type="text/css" href="../css/base.css" />
<link rel="stylesheet" type="text/css" href="../css/global.css" />
<link rel="stylesheet" type="text/css" href="../css/kotobeeInteractive.css" />

    <script type="text/javascript" src="../../../../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../../../../js/global.js"></script>
<script type="text/javascript" src="../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../js/global.js"></script>

    <title>Nausea and vomiting</title>
    
<meta name="m-checksum" content="2101814252" />

<meta charset="utf-8" />
 <meta name="kotobee-chapter" content="epubypzqs/EPUB/xhtml/ssq7bq.xhtml" />
<meta name="kotobee-book" content="urn:uuid:50c18eb5-de5f-e4ec-f125-398fa4eb456b" />
</head>
<body>
<p>Treat, if possible, underlying contributing factors (e.g. hypercalcaemia, constipation, bowel obstruction)</p>

<p>Parenteral treatment (e.g. via CSCI) is typically required in patients who are vomiting. Converting to oral anti-emetics is often then appropriate after the patient has been stable for a few days. Sometimes nausea improves only slightly with mono-therapy and, in these cases, combination therapy with multiple drugs of different classes acting on different receptors is usually effective.</p>

<hr />
<p><em>If metabolic or toxic causes are suspected (e.g. uraemia, medication-induced) -&gt;&#160;</em>haloperidol is a good first option, e.g.</p>

<ul>
	<li>Haloperidol 0.5mg twice daily orally (or 1mg via CSCI daily)</li>
	<li>AND/OR haloperidol 0.5mg 4-hourly PRN orally or subcut</li>
</ul>

<hr />
<p><em>If gastric stasis or distension is probably the main mechanism (or the main mechanism is unclear) -&gt;&#160;</em>metoclopramide is a good first option (or domperidone if at risk of extrapyramidal symptoms), e.g.</p>

<ul>
	<li>Metoclopramide 10mg three times daily pre-meals orally (or 30mg/24hrs via CSCI)</li>
	<li>AND/OR Metoclopramide 10mg three times daily PRN orally or subcut</li>
</ul>

<hr />
<p><em>If vestibular pathology is the main mechanism</em> <em>(e.g. movement induced or vertigo) -&gt;</em>&#160;antihistamine-antiemetics are good first options, e.g.</p>

<ul>
	<li>Prochlorperazine 5mg orally three times a day</li>
	<li>Cyclizine <em><sup>(non-PBS)</sup></em> 50mg three times a day orally or subcut either regularly or PRN (or 150mg via CSCI daily)</li>
</ul>

<hr />
<p><em>Further options for nausea include -&gt;</em></p>

<ul>
	<li>Steroids, e.g. dexamethasone (especially if nausea related to raised intra-cranial pressure)</li>
	<li>Benzodiazepines, e.g. lorazepam <em><sup>(non-PBS) </sup></em>0.5mg 6-hourly sublingually PRN (if anxiety is contributing)</li>
</ul>

<p><em>If nausea persists</em>&#160;-&gt;&#160;consider <em>adding or changing </em>to an anti-emetic that works on different receptors</p>

<ul>
	<li>Ondansetron <em><sup>(non-PBS indication)</sup></em> 8mg orally or 4mg subcut or sublingual twice daily</li>
	<li>OR Levomepromazine <em><sup>(special access scheme)</sup></em>&#160; 6.25mg orally or subcut twice daily</li>
</ul>

<hr />
<p><strong>Be alert to extra-pyramidal side effects</strong> with dopamine antagonist.</p>

<ul>
	<li>Acute dystonic reactions can be reversed with benztropine 2 mg IV or IM</li>
</ul>


</body></html>